| elastic fiber assembly | GO:0048251 | 4 | 0.999 | |
| extracellular structure organization | GO:0043062 | 148 | 0.962 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.962 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.936 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.913 | |
| bone development | GO:0060348 | 120 | 0.902 | |
| skeletal system development | GO:0001501 | 356 | 0.894 | |
| collagen fibril organization | GO:0030199 | 32 | 0.888 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.881 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.872 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.834 | |
| connective tissue development | GO:0061448 | 179 | 0.829 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.807 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.789 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.787 | |
| bone trabecula morphogenesis | GO:0061430 | 12 | 0.786 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.785 | |
| regulation of cell migration | GO:0030334 | 219 | 0.764 | |
| respiratory tube development | GO:0030323 | 167 | 0.728 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.714 | |
| appendage development | GO:0048736 | 166 | 0.707 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.706 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.702 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.700 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.693 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.644 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.639 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.630 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.624 | |
| lung development | GO:0030324 | 164 | 0.598 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.595 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.591 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.559 | |
| inflammatory response | GO:0006954 | 244 | 0.541 | |
| regulation of cell motility | GO:2000145 | 236 | 0.532 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.526 | |
| bone morphogenesis | GO:0060349 | 78 | 0.521 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.517 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.508 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.508 | |
| fibril organization | GO:0097435 | 2 | 0.502 | |
| regulation of protein transport | GO:0051223 | 163 | 0.496 | |
| renal system development | GO:0072001 | 225 | 0.468 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.459 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.457 | |
| regulation of protein localization | GO:0032880 | 231 | 0.446 | |
| bone trabecula formation | GO:0060346 | 9 | 0.443 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.436 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.423 | |
| bone mineralization | GO:0030282 | 54 | 0.423 | |
| artery development | GO:0060840 | 53 | 0.417 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.412 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.405 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.397 | |
| bone resorption | GO:0045453 | 38 | 0.396 | |
| limb morphogenesis | GO:0035108 | 149 | 0.389 | |
| angiogenesis | GO:0001525 | 201 | 0.382 | |
| response to growth factor | GO:0070848 | 198 | 0.380 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.377 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.377 | |
| kidney epithelium development | GO:0072073 | 121 | 0.376 | |
| mapk cascade | GO:0000165 | 281 | 0.373 | |
| cell adhesion | GO:0007155 | 329 | 0.367 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.366 | |
| respiratory system development | GO:0060541 | 190 | 0.362 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.357 | |
| ossification | GO:0001503 | 216 | 0.356 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.352 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.349 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.346 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.344 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.341 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.338 | |
| ureteric bud development | GO:0001657 | 94 | 0.337 | |
| response to oxygen radical | GO:0000305 | 16 | 0.335 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.334 | |
| head morphogenesis | GO:0060323 | 34 | 0.330 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.330 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.324 | |
| biomineral tissue development | GO:0031214 | 64 | 0.313 | |
| ear development | GO:0043583 | 200 | 0.309 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.308 | |
| urogenital system development | GO:0001655 | 261 | 0.304 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.303 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.298 | |
| renal tubule development | GO:0061326 | 87 | 0.292 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.290 | |
| axonogenesis | GO:0007409 | 274 | 0.287 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.284 | |
| forebrain development | GO:0030900 | 302 | 0.283 | |
| regulation of system process | GO:0044057 | 200 | 0.282 | |
| regulation of secretion | GO:0051046 | 274 | 0.280 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.278 | |
| protein secretion | GO:0009306 | 111 | 0.278 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.274 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.273 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.273 | |
| tissue homeostasis | GO:0001894 | 115 | 0.271 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.264 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.264 | |
| nephron development | GO:0072006 | 109 | 0.263 | |
| amine metabolic process | GO:0009308 | 45 | 0.260 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.259 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.255 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.253 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.253 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.252 | |
| tissue remodeling | GO:0048771 | 102 | 0.246 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.244 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.240 | |
| chondrocyte development | GO:0002063 | 24 | 0.232 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.231 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.230 | |
| palate development | GO:0060021 | 76 | 0.225 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.224 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.221 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.215 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.214 | |
| response to oxidative stress | GO:0006979 | 123 | 0.213 | |
| metanephric nephron development | GO:0072210 | 34 | 0.212 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.211 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.209 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.208 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.207 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.203 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.203 | |
| muscle system process | GO:0003012 | 141 | 0.197 | |
| cartilage development | GO:0051216 | 140 | 0.195 | |
| cell chemotaxis | GO:0060326 | 81 | 0.193 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.192 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.192 | |
| limb development | GO:0060173 | 166 | 0.192 | |
| glomerulus development | GO:0032835 | 40 | 0.189 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.179 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.175 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.175 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.174 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.174 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.174 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.172 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.170 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.169 | |
| skin development | GO:0043588 | 220 | 0.169 | |
| actin filament organization | GO:0007015 | 113 | 0.168 | |
| axon guidance | GO:0007411 | 141 | 0.165 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.164 | |
| neuron migration | GO:0001764 | 122 | 0.163 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.159 | |
| circulatory system process | GO:0003013 | 197 | 0.159 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.158 | |
| cytokine production | GO:0001816 | 319 | 0.155 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.155 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.155 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.154 | |
| sequestering of bmp in extracellular matrix | GO:0035582 | 3 | 0.153 | |
| regulation of ossification | GO:0030278 | 112 | 0.151 | |
| endocytosis | GO:0006897 | 168 | 0.151 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.150 | |
| leukocyte migration | GO:0050900 | 124 | 0.148 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.148 | |
| kidney development | GO:0001822 | 213 | 0.144 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.143 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.142 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.140 | |
| developmental maturation | GO:0021700 | 193 | 0.140 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.140 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.139 | |
| protein catabolic process | GO:0030163 | 221 | 0.138 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.138 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.136 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.135 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.134 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.133 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.132 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.132 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.132 | |
| muscle tissue development | GO:0060537 | 308 | 0.131 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.131 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.130 | |
| innate immune response | GO:0045087 | 157 | 0.129 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.129 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.129 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.127 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.127 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.127 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.127 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.127 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.126 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.126 | |
| digestive system development | GO:0055123 | 200 | 0.125 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.125 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.125 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.123 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.123 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.121 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.121 | |
| muscle contraction | GO:0006936 | 101 | 0.120 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.119 | |
| stem cell development | GO:0048864 | 219 | 0.118 | |
| face development | GO:0060324 | 38 | 0.117 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.117 | |
| rhythmic process | GO:0048511 | 174 | 0.117 | |
| response to superoxide | GO:0000303 | 16 | 0.116 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.115 | |
| regeneration | GO:0031099 | 38 | 0.115 | |
| renal system process | GO:0003014 | 48 | 0.112 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.112 | |
| cytokine secretion | GO:0050663 | 72 | 0.110 | |
| oviduct development | GO:0060066 | 3 | 0.109 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.106 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.106 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.105 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.104 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.104 | |
| positive regulation of interferon gamma secretion | GO:1902715 | 3 | 0.104 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.104 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.103 | |
| sterol esterification | GO:0034434 | 3 | 0.103 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.102 | |
| protein activation cascade | GO:0072376 | 19 | 0.102 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.102 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.099 | |
| negative regulation of growth | GO:0045926 | 99 | 0.099 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.098 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.097 | |
| ear morphogenesis | GO:0042471 | 118 | 0.097 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.096 | |
| sa node cell action potential | GO:0086015 | 4 | 0.096 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.095 | |
| oxidation reduction process | GO:0055114 | 342 | 0.094 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.094 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.093 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.093 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.092 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.091 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.091 | |
| trabecula formation | GO:0060343 | 24 | 0.090 | |
| blood circulation | GO:0008015 | 195 | 0.090 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.090 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.090 | |
| forebrain cell migration | GO:0021885 | 58 | 0.088 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.088 | |
| negative regulation of chondrocyte differentiation | GO:0032331 | 13 | 0.087 | |
| cell recognition | GO:0008037 | 83 | 0.086 | |
| cellular response to bmp stimulus | GO:0071773 | 14 | 0.085 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.085 | |
| regulation of heart rate | GO:0002027 | 36 | 0.084 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.083 | |
| notochord development | GO:0030903 | 20 | 0.082 | |
| nephron tubule development | GO:0072080 | 84 | 0.082 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.082 | |
| lipid modification | GO:0030258 | 65 | 0.082 | |
| endoderm development | GO:0007492 | 45 | 0.081 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.081 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.081 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.081 | |
| neuron projection guidance | GO:0097485 | 141 | 0.080 | |
| cardiac cell development | GO:0055006 | 41 | 0.080 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.080 | |
| replacement ossification | GO:0036075 | 26 | 0.079 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.079 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.078 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.078 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.077 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.077 | |
| positive regulation of fibronectin dependent thymocyte migration | GO:2000415 | 1 | 0.075 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.075 | |
| regionalization | GO:0003002 | 337 | 0.074 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.074 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.074 | |
| cardiac septum development | GO:0003279 | 59 | 0.074 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.073 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.073 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.073 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.073 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.072 | |
| mesonephros development | GO:0001823 | 97 | 0.071 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.071 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.070 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.070 | |
| camera type eye development | GO:0043010 | 266 | 0.069 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.068 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.068 | |
| cell aggregation | GO:0098743 | 18 | 0.068 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.067 | |
| multicellular organism growth | GO:0035264 | 161 | 0.066 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.066 | |
| steroid metabolic process | GO:0008202 | 119 | 0.064 | |
| organ growth | GO:0035265 | 117 | 0.064 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.063 | |
| wound healing | GO:0042060 | 157 | 0.063 | |
| response to amino acid | GO:0043200 | 37 | 0.063 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.063 | |
| male gamete generation | GO:0048232 | 285 | 0.063 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.063 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.063 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.063 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.062 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.061 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.061 | |
| protein oligomerization | GO:0051259 | 67 | 0.061 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.061 | |
| gland development | GO:0048732 | 330 | 0.061 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.061 | |
| aorta development | GO:0035904 | 23 | 0.061 | |
| heart trabecula formation | GO:0060347 | 14 | 0.060 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.060 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.060 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.060 | |
| cognition | GO:0050890 | 149 | 0.060 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.059 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.059 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.059 | |
| neuron death | GO:0070997 | 154 | 0.059 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.059 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.059 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.059 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.059 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.059 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.058 | |
| protein trimerization | GO:0070206 | 13 | 0.058 | |
| sensory perception of sound | GO:0007605 | 97 | 0.058 | |
| regulation of transmission of nerve impulse | GO:0051969 | 1 | 0.057 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.057 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.057 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.057 | |
| eosinophil migration | GO:0072677 | 3 | 0.057 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.056 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.056 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.056 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.056 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.056 | |
| hormone secretion | GO:0046879 | 128 | 0.055 | |
| cerebellum development | GO:0021549 | 77 | 0.055 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.055 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.054 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.053 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.053 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.053 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.053 | |
| heart morphogenesis | GO:0003007 | 178 | 0.053 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.052 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.052 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.052 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.052 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.052 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.052 | |
| sensory perception | GO:0007600 | 245 | 0.051 | |
| cell fate commitment | GO:0045165 | 210 | 0.051 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.051 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.051 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.050 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.050 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.050 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.049 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.049 | |
| positive regulation of adiponectin secretion | GO:0070165 | 1 | 0.049 | |
| response to oxygen levels | GO:0070482 | 62 | 0.048 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.048 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.048 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.048 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.048 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.048 | |
| calcium ion transport | GO:0006816 | 159 | 0.048 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.047 | |
| spermatogenesis | GO:0007283 | 284 | 0.046 | |
| hexose metabolic process | GO:0019318 | 98 | 0.046 | |
| positive regulation of bone resorption | GO:0045780 | 13 | 0.046 | |
| epidermis development | GO:0008544 | 187 | 0.046 | |
| regulation of metalloenzyme activity | GO:0048552 | 4 | 0.046 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.045 | |
| mesangial cell development | GO:0072143 | 4 | 0.045 | |
| cellular response to peptide | GO:1901653 | 92 | 0.045 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.045 | |
| regulation of bone resorption | GO:0045124 | 24 | 0.045 | |
| locomotory behavior | GO:0007626 | 195 | 0.044 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.044 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.044 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.044 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.044 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.044 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.044 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.044 | |
| activation of immune response | GO:0002253 | 138 | 0.044 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.043 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.043 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.043 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.043 | |
| endocrine process | GO:0050886 | 39 | 0.043 | |
| digestive tract development | GO:0048565 | 190 | 0.043 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.043 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.043 | |
| nephron epithelium development | GO:0072009 | 92 | 0.042 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.042 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.042 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.041 | |
| chondrocyte hypertrophy | GO:0003415 | 4 | 0.041 | |
| female gonad development | GO:0008585 | 71 | 0.041 | |
| response to bmp | GO:0071772 | 14 | 0.041 | |
| lung alveolus development | GO:0048286 | 45 | 0.041 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.041 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.040 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.040 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.040 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.040 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.040 | |
| transmembrane transport | GO:0055085 | 412 | 0.040 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.040 | |
| extracellular fibril organization | GO:0043206 | 2 | 0.039 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.039 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.039 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.038 | |
| detection of mechanical stimulus involved in equilibrioception | GO:0050973 | 2 | 0.038 | |
| regulation of tube size | GO:0035150 | 57 | 0.038 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.038 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.038 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.038 | |
| endochondral bone growth | GO:0003416 | 19 | 0.038 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.037 | |
| cell communication by electrical coupling | GO:0010644 | 4 | 0.037 | |
| regulation of cell growth involved in cardiac muscle cell development | GO:0061050 | 3 | 0.037 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.037 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.037 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.037 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.036 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.036 | |
| response to drug | GO:0042493 | 75 | 0.036 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.036 | |
| negative regulation of neuron migration | GO:2001223 | 6 | 0.036 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.036 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.036 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.035 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.035 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.035 | |
| face morphogenesis | GO:0060325 | 29 | 0.035 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.034 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.034 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.034 | |
| phagocytosis | GO:0006909 | 66 | 0.034 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.033 | |
| glucose homeostasis | GO:0042593 | 128 | 0.033 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.033 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.033 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.033 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.033 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.032 | |
| glomerular epithelial cell differentiation | GO:0072311 | 10 | 0.032 | |
| lymphocyte migration | GO:0072676 | 26 | 0.032 | |
| defense response to bacterium | GO:0042742 | 119 | 0.032 | |
| neural crest cell development | GO:0014032 | 48 | 0.032 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.032 | |
| regulation of adiponectin secretion | GO:0070163 | 2 | 0.032 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.032 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.031 | |
| response to acid chemical | GO:0001101 | 111 | 0.031 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.031 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.031 | |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 11 | 0.031 | |
| sperm egg recognition | GO:0035036 | 37 | 0.031 | |
| sequestering of extracellular ligand from receptor | GO:0035581 | 6 | 0.030 | |
| prevention of polyspermy | GO:0060468 | 4 | 0.030 | |
| lateral inhibition | GO:0046331 | 1 | 0.030 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.030 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.030 | |
| embryonic placenta development | GO:0001892 | 98 | 0.030 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.030 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.030 | |
| renal outer medulla development | GO:0072054 | 2 | 0.029 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.029 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.029 | |
| mesenchyme development | GO:0060485 | 152 | 0.029 | |
| learning or memory | GO:0007611 | 148 | 0.029 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.029 | |
| heart contraction | GO:0060047 | 93 | 0.029 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.028 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.028 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.028 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.028 | |
